The Gordon model allows for the fact that the market might put a price on a stock that's different from what you might estimate using the equation above. A higher stock price than predicted implies a ...

Discover key Q3 2025 insights for California Water Service Group, including infrastructure investment, financial growth, and regulatory updates.

Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

CRISPR Therapeutics has an approved gene-editing therapy, Casgevy, which can be a game changer for patients who need it. The company continues to burn through cash, but its financial position remains ...

Two leading U.S.-based retailers witnessed big spikes in their Growth metrics in Benzinga’s Edge Stock Rankings over the past week alone, hinting at a renewed momentum and a major turnaround. The ...

Dollar Tree sees a light at the end of the tunnel for tariff-mitigation costs, which should lead to accelerated earnings growth Off-price retailer Dollar Tree is hosting an investor event Wednesday.

HONG KONG (AP) — China's economy expanded at the slowest annual pace in a year in July-September, growing 4.8%, weighed down by trade tensions with the United States and slack domestic demand. The ...

The innovation dividend represents the durable value AI brings by enabling new products, services and revenue channels.

Prologis is poised for accelerated growth, driven by rebounding logistics demand and a strategic push into high-margin data center development. With logistics supply tightening and in-place rents far ...

A recent revenue miss and actions by its top competitors have weighed on The Trade Desk stock. Its growth continues despite its challenges. The Trade Desk's valuation is becoming increasingly ...

Robinhood is expected to increase revenue at a compound annual growth rate of 15.5% from 2025 through 2027, based on consensus estimates among analysts polled by LSEG. But investors seem to have ...

Key market opportunities in the omics-based clinical trials sector include the rising adoption of personalized medicine, ...